CALL/MERCK & CO./100/0.1/17.01.25 | Real-time BOERSE MUENCHEN 06:25:47 2024-06-03 EDT | ||
| 2.61 EUR | +1.40% |
|
| 1 month | -14.37% | ||
| 3 months | -9.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 2.61 | +1.40% |
| 24-05-31 | 2.574 | -6.77% |
| 24-05-30 | 2.761 | +4.78% |
| 24-05-29 | 2.635 | -0.08% |
| 24-05-28 | 2.637 | -9.69% |
Real-time BOERSE MUENCHEN
Last update June 03, 2024 at 06:25 am
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GZ7P00 |
| ISIN | DE000GZ7P007 |
| Date issued | 2023-01-23 |
| Strike | 100 $ |
| Maturity | 2025-01-17 (229 Days) |
| Parity | 10 : 1 |
| Emission price | 1.94 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.34 € |
|---|---|
| Lowest since issue | 0.957 € |
| Spread | 0.05 € |
| Spread % | 1.89% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Warrants
- Warrant
